Pharmacological reactivation of autophagic flux by natural compounds or synthetic cell-permeable peptide prevents doxorubicin-induced cardiomyopathy
Basic Research in Cardiology · 29.03.2026 · 121 (3) · 523-539
DOI: 10.1007/s00395-026-01174-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 29.03.2026. Verfasst von Leonardo Schirone und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Life Sciences, European University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Doxorubicin, Autophagy, Trehalose, Spermidine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Roma La Sapienza.
Abstract (Originalsprache)
Therapeutic strategies to limit doxorubicin (DOX)-induced cardiomyopathy are still limited due to incomplete characterization of the underlying molecular mechanisms. The exogenous activation of autophagy was reported to exert cardioprotective effects in preclinical models of cardiovascular diseases. We tested whether restoration of autophagy by different pharmacological approaches can reduce DOX-induced cardiomyopathy. A validated preclinical murine model of DOX-induced cardiotoxicity (final cumulative dose of 15 mg/kg) was used to test the cardiac effects of both natural (trehalose and spermidine) and synthetic (Tat-Beclin 1 D11) activators of autophagy. Cardiac function was evaluated by echocardiographic analyses. We performed histological analyses (Masson trichrome staining, TUNEL assay) to investigate fibrosis and apoptosis. Biomolecular analyses, confocal and transmission electron microscopy were used to assess levels of autophagy, autophagic flux, mitophagy and mitochondrial alterations. We also evaluated the effects of autophagy activators in a validated syngeneic model with subcutaneous injection of breast cancer cells treated with DOX. We found that DOX-induced cardiotoxicity is associated with impaired autophagic flux (accumulation of LC3-II and p62). Reactivation of autophagic flux by trehalose or spermidine rescues cardiac function and cardiomyocyte survival in mice treated with DOX, along with an overall amelioration of mitochondrial health and mitophagy. Selective reactivation of autophagy by Tat-Beclin 1 D11 also recapitulates the protective effects exerted by trehalose and spermidine. Autophagy activators preserve cardiac function without affecting the antineoplastic effects of DOX in mice with cancer. Boosting autophagic flux is a suitable therapeutic approach to prevent cardiotoxicity induced by anthracyclines. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health and Life Sciences, European University of Rome, Rome, Italy.
- Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso Della Repubblica 79, Latina, Italy.
- Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy.
- Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, Italy.
- Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy.
- Department of Medicine, University of Verona School of Medicine, Verona University Hospital Trust, Verona, Italy.
Förderung
- Università degli Studi di Roma La Sapienza
Zitieren
APA
Schirone, L., Vecchio, D., Valenti, V., Picchio, V., Schiavon, S., D'Ambrosio, L., di Nonno, F., Miglietta, S., Relucenti, M., Madaro, L., Palmerio, S., Cozzolino, C., Litterio, M., Sarto, G., Simeone, B., Moro, N., Tahir, S., Zaglia, T., Zoccai, G. B., …, & Sciarretta, S. (2026). Pharmacological reactivation of autophagic flux by natural compounds or synthetic cell-permeable peptide prevents doxorubicin-induced cardiomyopathy. Basic Research in Cardiology, 121(3), 523-539. https://doi.org/10.1007/s00395-026-01174-9
Vancouver
Schirone L, Vecchio D, Valenti V, Picchio V, Schiavon S, D'Ambrosio L, et al. Pharmacological reactivation of autophagic flux by natural compounds or synthetic cell-permeable peptide prevents doxorubicin-induced cardiomyopathy. Basic Research in Cardiology. 2026;121(3):523-539. doi:10.1007/s00395-026-01174-9
BibTeX
@article{Schirone2026,
author = {Schirone, Leonardo and Vecchio, Daniele and Valenti, Valentina and Picchio, Vittorio and Schiavon, Sonia and D'Ambrosio, Luca and di Nonno, Flavio and Miglietta, Selenia and Relucenti, Michela and Madaro, Luca and Palmerio, Silvia and Cozzolino, Claudia and Litterio, Margherita and Sarto, Gianmarco and Simeone, Beatrice and Moro, Nicola and Tahir, Shazia and Zaglia, Tania and Zoccai, Giuseppe Biondi and De Falco, Elena and Petrozza, Vincenzo and Greco, Ernesto and Frati, Giacomo and Forte, Maurizio and Sciarretta, Sebastiano},
title = {Pharmacological reactivation of autophagic flux by natural compounds or synthetic cell-permeable peptide prevents doxorubicin-induced cardiomyopathy},
journal = {Basic Research in Cardiology},
year = {2026},
volume = {121},
number = {3},
pages = {523--539},
doi = {10.1007/s00395-026-01174-9}
}
EUVIMED